With reference to the SEBI Circular-SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, in respect of fund raising by issuance of Debt Securities by Large Entities, Sequent Scientific has confirmed that for the financial year ended March 31, 2020, the Company is ‘Not a Large Corporate’ as per the framework provided in the aforesaid Circular.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1676.00 |
| Dr. Reddys Lab | 1234.90 |
| Cipla | 1239.00 |
| Zydus Lifesciences | 947.70 |
| Lupin | 2332.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: